An early-stage investment and development firm located in the US Mountain West has more than $300 million in assets and operates under an “Evergreen” structure. The firm is flexible in investment size and structure, but prefer initial investments in the $1M – $3M range.
The firm invests in medical devices, therapeutics, diagnostics and research tools. RCT focuses on medical devices that can be approved under the 510(k) guidelines, and prefers therapeutic product generating platforms and research tools platforms. For therapeutics, RCT prefers investments at an early-stage, from pre-clinical up to Phase I.
The firm seeks to invest in small, early-stage companies with a lean but strong and qualified management / execution team. The firm prefers to invest in companies in the U.S., but will consider opportunities in Europe, Israel and Australia.
If you are interested in more information about this investor and other investors tracked by LSN, please email email@example.com